Status:
TERMINATED
The Effects of Animal Assisted Therapy in Outpatient Psychiatry Clinics
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Anxiety
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine whether a session of animal-assisted therapy reduces anxiety levels and improves long-term clinical outcomes of outpatient psychiatric patients in regard to their Generalized A...
Detailed Description
Previous research regarding the value and benefits of Animal-Assisted Therapy (AAT) has often been focused on outcomes within In-Patient settings. One project showed that AATs may offer a decrease in ...
Eligibility Criteria
Inclusion
- Outpatient psychiatric patients of Dr. Matt Kern who meet the criteria to be diagnosed with Major Depressive Disorder and/or Generalized Anxiety Disorder via Patient Health Questionnaire (PHQ-9) and/or General Anxiety Disorder (GAD-7)
Exclusion
- Prior history of animal related trauma
- Participants that require psychiatric hospitalization during the experiment will have their information excluded from analysis
- Participants who have changes made to any Hypertension / Blood Pressure medications during the experiment will have their Blood Pressure measurements removed from final analysis
Key Trial Info
Start Date :
July 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 11 2022
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05326074
Start Date
July 8 2022
End Date
August 11 2022
Last Update
June 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157